Activez les alertes d’offres d’emploi par e-mail !

Post-doctoral (M/F) in nanomedicine

European Commission

France

Sur place

EUR 30 000 - 40 000

Plein temps

Il y a 2 jours
Soyez parmi les premiers à postuler

Générez un CV personnalisé en quelques minutes

Décrochez un entretien et gagnez plus. En savoir plus

Repartez de zéro ou importez un CV existant

Résumé du poste

Une unité multidisciplinaire recherche un chercheur post-doctoral en nanomédecine pour étudier les effets immunomodulateurs des nanoparticules. Le candidat participera à des projets innovants visant le développement de thérapies personnalisées. Ce poste offre l'opportunité de travailler avec des experts dans un environnement dynamique et transdisciplinaire.

Qualifications

  • PhD obtenu de préférence en 2024.
  • Connaissances approfondies en biophysique ou bioingénierie.
  • Expérience souhaitée en culture cellulaire et modèles 3D.

Responsabilités

  • Mettre en place des modèles 3D d'athérosclérose et des tumeurs fibreuses.
  • Incorporer des cellules immunitaires et étudier leur comportement.
  • Analyser les effets des nanoparticules dans les modèles.

Connaissances

Culture cellulaire
Modèles 3D
Nanoparticules
Microfluidique
Immunologie

Formation

Doctorat en biophysique, bioingénierie ou nanomédecine

Description du poste

Organisation/Company CNRS Department NAnomédecine, Biologie extracellulaire, Intégratome et Innovations Research Field Pharmacological sciences Engineering Technology Researcher Profile Recognised Researcher (R2) Country France Application Deadline 31 Jul 2025 - 23:59 (UTC) Type of Contract Temporary Job Status Full-time Hours Per Week 35 Offer Starting Date 7 Aug 2025 Is the job funded through the EU Research Framework Programme? Not funded by a EU programme Is the Job related to staff position within a Research Infrastructure? No

Offer Description

Metallic nanoparticles activated or not by an external stimulus (laser, alternating magnetic field) can generate effects on the immune system that are favourable in certain tissue repair or anti-cancer therapy strategies. The aim will be to assess the immunomodulatory effects of metallic nanoparticles activated or not by external fields in three-dimensional models of atherosclerotic plaques or fibrous tumours. The focus will be on the immune infiltrate as a function of the physical properties of the extracellular matrix for different types of nanoparticles/stimuli.

- Setting up a 3D model of atherosclerosis and fibrous tumours and studying its mechanical properties.
- Incorporating immune cells into these 3D models and studying their behaviour.
- Screening the effect of nanoparticles on these 3D models, with or without exposure to external stimuli.
- Set up multivariate analyses and machine learning tools to screen the immune microenvironment in these models.

The new multidisciplinary NABI unit (Nanomedicine, Extracellular Biology, Integratome and Innovations in Health) on the Saint Germain Campus of Université Paris Cité (45 rue des Saints Pères, 75006 Paris) has been created on 1 January 2025 and brings together around 70 physicists, biologists, pharmacists, engineers and doctors, including around 30 permanent staff, under the supervision of CNRS, INSERM and Université Paris Cité. The scientific objectives of NABI are to develop new therapies based on biological nano-objects (extracellular vesicles) or synthetic nano-objects (activatable metallic nanoparticles) for the delivery of personalised therapies for pathologies that are difficult to treat. The study of nano-objects in biological fluids requires trans-disciplinary approaches (physics, engineering, cellular and molecular biology, immunology, etc.) right through to clinical practice and dedicated technical and analytical resources (super-resolution microscopy, nanoprobes, microfluidics, etc.) as well as systematic multimodal and multi-scale exploration, the analysis of which calls on AI.
These innovative methodologies are developed within NABI and the industrial integrator IVETh, a technology hub dedicated to the characterisation, bioproduction and engineering of extracellular vesicles and nanovectors for diagnosis and personalised therapies. The post doctoral researcher will join the multidisciplinary 'Nanobiotherapies' team as part of the ANR NanoHypMPI project.

As part of an ANR project, we are looking for a post-doctoral researcher. The PhD should preferably be obtained in 2024, with in-depth knowledge of biophysics or bioengineering or nanomedicine. Desired experience in :
- cell culture and 3D models (organoids)
- nanoparticles and their interaction with the biological environment and/or external excitation fields
- microfluidics
- immunology

Obtenez votre examen gratuit et confidentiel de votre CV.
ou faites glisser et déposez un fichier PDF, DOC, DOCX, ODT ou PAGES jusqu’à 5 Mo.